Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
Large-leaf yellow tea oligosaccharides alleviate T2DM by promoting GLP-1 secretion and regulating intestinal mucosal barrier.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wu Han, Xie Hai, Li Minni, Li Yidi, Wang Xinyi, Xu Na, Ge Huifang, Xie Zhongwen, Wang Yijun, Li Daxiang, Wang Hongyan
Аннотация
BACKGROUND: Glucagon-like peptide-1 (GLP-1), a key incretin produced by intestinal L-cells, plays a vital role in glucose and intestinal homeostasis during type 2 diabetes mellitus (T2DM) management. Large-leaf yellow tea polysaccharide (LYP) exhibits hypoglycemic effects, yet the structural features of LYP-derived bioactive oligosaccharides and their potential effects and mechanisms in promoting GLP-1 secretion remain unclear.
PURPOSE: This study aimed to isolate an active oligosaccharide from LYP and explore its effects and underlying mechanisms on GLP-1 secretion and intestinal homeostasis in T2DM.
METHODS: An oligosaccharide (ELYP) was obtained from enzymatic degradation of LYP guided by activity evaluation. Its structure was characterized, and in situ intestinal perfusion was used to assess GLP-1 secretion in mice. Molecular mechanisms were explored in T2DM mice and STC-1 cells. Intestinal microorganisms and metabolites, intestinal barrier integrity, as well as immunocytes profiles were analyzed.
RESULTS: ELYP primarily consists of 1,4-linked β-GalpA and 1,4-linked β-Glcp, with degrees of polymerization between 3 to 7. It significantly increased plasma GLP-1 levels and upregulated genes related to GLP-1 synthesis, processing, and release synthesis and secretion. ELYP also restored intestinal barrier function by enhancing tight-junction proteins and goblet cell numbers, enriching beneficial gut microbiota and SCFAs composition, and promoting a transition of macrophages and T lymphocytes to an anti-inflammatory phenotype.
CONCLUSION: ELYP effectively ameliorates T2DM by potently stimulating GLP-1 secretion and restoring intestinal homeostasis. This study not only identifies ELYP as a promising natural product for T2DM management but also provides new insights into the mechanism of tea-derived oligosaccharides.
PURPOSE: This study aimed to isolate an active oligosaccharide from LYP and explore its effects and underlying mechanisms on GLP-1 secretion and intestinal homeostasis in T2DM.
METHODS: An oligosaccharide (ELYP) was obtained from enzymatic degradation of LYP guided by activity evaluation. Its structure was characterized, and in situ intestinal perfusion was used to assess GLP-1 secretion in mice. Molecular mechanisms were explored in T2DM mice and STC-1 cells. Intestinal microorganisms and metabolites, intestinal barrier integrity, as well as immunocytes profiles were analyzed.
RESULTS: ELYP primarily consists of 1,4-linked β-GalpA and 1,4-linked β-Glcp, with degrees of polymerization between 3 to 7. It significantly increased plasma GLP-1 levels and upregulated genes related to GLP-1 synthesis, processing, and release synthesis and secretion. ELYP also restored intestinal barrier function by enhancing tight-junction proteins and goblet cell numbers, enriching beneficial gut microbiota and SCFAs composition, and promoting a transition of macrophages and T lymphocytes to an anti-inflammatory phenotype.
CONCLUSION: ELYP effectively ameliorates T2DM by potently stimulating GLP-1 secretion and restoring intestinal homeostasis. This study not only identifies ELYP as a promising natural product for T2DM management but also provides new insights into the mechanism of tea-derived oligosaccharides.